95
Views
14
CrossRef citations to date
0
Altmetric
Review

Expanding the repertoire of RNA interference screens for developing new anticancer drug targets

Pages 1429-1441 | Published online: 26 Oct 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Dae-Dong Kim & Cathy Eng. (2012) The promise of mTOR inhibitors in the treatment of colorectal cancer. Expert Opinion on Investigational Drugs 21:12, pages 1775-1788.
Read now
Shou-Li Wang, Hui-Hua Yao & Zheng-Hong Qin. (2009) Strategies for short hairpin RNA delivery in cancer gene therapy. Expert Opinion on Biological Therapy 9:11, pages 1357-1368.
Read now
Chuan Huang, Min Li, Changyi Chen & Qizhi Yao. (2008) Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications. Expert Opinion on Therapeutic Targets 12:5, pages 637-645.
Read now

Articles from other publishers (11)

Nana Guo, Chen Gao, Jing Liu, Jun Li, Nan Liu, Yanli Hao, Lei Chen & Xiaoning Zhang. (2018) Reversal of Ovarian Cancer Multidrug Resistance by a Combination of LAH4-L1-siMDR1 Nanocomplexes with Chemotherapeutics. Molecular Pharmaceutics 15:5, pages 1853-1861.
Crossref
Christiane Schaefer, Nikhil Mallela, Jochen Seggewiß, Birgit Lechtape, Heymut Omran, Uta Dirksen, Eberhard Korsching & Jenny Potratz. (2018) Target discovery screens using pooled shRNA libraries and next-generation sequencing: A model workflow and analytical algorithm. PLOS ONE 13:1, pages e0191570.
Crossref
Mahmoud Kandeel, Abdullah Al-Taher, Remi Nakashima, Tomoya Sakaguchi, Ali Kandeel, Yuki Nagaya, Yoshiaki Kitamura & Yukio Kitade. (2014) Bioenergetics and Gene Silencing Approaches for Unraveling Nucleotide Recognition by the Human EIF2C2/Ago2 PAZ Domain. PLoS ONE 9:5, pages e94538.
Crossref
Wen-Shuang Wang, Xing-Sheng Yang, Min Xia, Hai-Yang Jiang & Jian-Qing Hou. (2012) Silencing of Twist Expression by RNA Interference Suppresses Epithelial-mesenchymal Transition, Invasion, and Metastasis of Ovarian Cancer. Asian Pacific Journal of Cancer Prevention 13:9, pages 4435-4439.
Crossref
Danli L. Towne, Emily E. Nicholl, Kenneth M. Comess, Scott C. Galasinski, Philip J. Hajduk & Vivek C. Abraham. (2012) Development of a High-Content Screening Assay Panel to Accelerate Mechanism of Action Studies for Oncology Research. SLAS Discovery 17:8, pages 1005-1017.
Crossref
Russell C. Langan, John Mullinax, Manish Raiji & Itzhak Avital. 2012. Regulatory RNAs. Regulatory RNAs 387 408 .
Russell C. Langan, John Mullinax, Manish Raiji & Itzhak Avital. 2012. Regulatory RNAs. Regulatory RNAs 387 408 .
Paul J. Smith, Roy Edward & Rachel J. Errington. 2010. Flow Cytometry in Drug Discovery and Development. Flow Cytometry in Drug Discovery and Development 23 54 .
Yan-Jie Zhang, Qiang Dai, Dan-Feng Sun, Hua Xiong, Xiao-Qing Tian, Feng-Hou Gao, Mang-Hua Xu, Guo-Qiang Chen, Ze-Guang Han & Jing-Yuan Fang. (2009) mTOR Signaling Pathway Is a Target for the Treatment of Colorectal Cancer. Annals of Surgical Oncology 16:9, pages 2617-2628.
Crossref
Anke Detzer, Marita Overhoff, Winfried Wünsche, Maria Rompf, John J. Turner, Gabriela D. Ivanova, Michael J. Gait & Georg Sczakiel. (2009) Increased RNAi is related to intracellular release of siRNA via a covalently attached signal peptide. RNA 15:4, pages 627-636.
Crossref
Klaus Strebhardt & Axel Ullrich. (2008) Paul Ehrlich's magic bullet concept: 100 years of progress. Nature Reviews Cancer 8:6, pages 473-480.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.